Severity
Critical
FDA Drug recall · Reported February 23, 2022
Non-sterility; bacterial contamination identified as Paenibacillus lautus.
Revive Rx LLC dba Revive Rx Pharmacy recalled HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV… - a critical-severity action.
HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV… was recalled by Revive Rx LLC dba Revive Rx Pharmacy in February 23, 2022. Reason: Non-sterility; bacterial contamination identified as Paenibacillus lautus.. Check the official notice for the remedy. Verify recall #D-0648-2022 with the FDA Drug before acting.
The recall
Revive Rx LLC dba Revive Rx Pharmacy issued this critical-severity FDA Drug recall-Non-sterility; bacterial contamination identified as Paenibacillus lautus..
Sourced from official FDA Drug enforcement records. Verify recall #D-0648-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0648-2022) was formally reported on February 23, 2022, with the manufacturer initiating the action on February 11, 2022. It is classified under Critical severity (Class I), with a current status of Terminated. Revive Rx LLC dba Revive Rx Pharmacy is listed as the recalling firm, operating out of Houston, TX. Federal records list the affected scope as 115 vials.
The documented reason for this recall is: Non-sterility; bacterial contamination identified as Paenibacillus lautus. Distribution data in the federal record shows the product reached: Nationwide in the US.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 510 outdoor & sports recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
115 vials
Related Recalls
6
0 from same agency
HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.
Non-sterility; bacterial contamination identified as Paenibacillus lautus.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0648-2022 |
| Date reported | February 23, 2022 |
| Date initiated | February 11, 2022 |
| Recalling firm | Revive Rx LLC dba Revive Rx Pharmacy |
| Firm location | Houston, TX |
| Affected scope | 115 vials |
| Distribution | Nationwide in the US. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Changsha Jiali Duo Technology Co., Ltd., dba Topyond, of China · 2026-07-02
Shenzhen Fuxiangyue Technology Co., Ltd., dba Arrogantf, of China · 2026-06-18
Foshan Nanhai District Haichen Tengfei Hardware Factory, of China · 2026-06-11
· 2026-06-11
Dongguanshizhouhedianzishangwuyouxiangongsi (Dongguan Zhouhe E-commerce Co., Ltd.) dba Gudook Outdoor Sports, of China · 2026-06-04
Compare this recall with Topyond Pool Drain Ports with Covers Recalled Due to Risk o… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 23, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.